It's a major step back from statements made at a White House news conference in September, when President Donald Trump and FDA commissioner Marty Makary announced the drug was under review to benefit ...

What is leucovorin? FDA expands drug’s approved use but walks back autism claims - Unresolved questions about the drug haven’t stopped U.S. doctors from prescribing it ...

Israel Can Still Strike. It Can No Longer Promise Control.

Financing Expected to Fund Completion of Phase 2 Ovarian Cancer TrialFinancing Supports Acceleration Toward Pivotal Trial and CommercializationFinancing Structured ...

TARPON SPRINGS, Fla., March 6, 2026 - Allarity Therapeutics, Inc. ("Allarity” or the "Company”) (NASDAQ: ALLR), a Phase 2 ...